Lab Notes: Pavella gets $5M payday from expanded partnership; Aclaris enters licensing deal



This week’s Lab Notes has items on a Wayne drug developer’s expanded partnership for a potential rare skin disease treatment, a Malvern medical technology company’s expanded regulatory approval overseas and more.



Source link